H in using inflammatory biomarkers, clinical inflammatory assessments, and imaging to quantify the PIR. A systematic literature search of eight major databases was conducted using a predetermined search strategy. C-reactive protein (CRP), interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), knee surface temperature (KST), and clinical outcome data were collected and graphically displayed. Eighty-six percent of the studies that reported a statistically significant decrease in inflammatory biomarkers in their treatment group demonstrated a concordant notable improvement in clinical outcome scores. Mean CRP, IL-6, ESR, and KST values peaked on postoperative day (POD) 2, POD1, POD7, and POD 1-3, respectively. The PIR is correlated with early pain and function recovery outcomes. Future studies comparing TKA surgical methodologies and perioperative protocols should assess PIR by incorporating inflammatory biomarkers, such as CRP and IL-6, and clinical inflammatory assessment adjuncts, to provide a more comprehensive comparison....
The timing of surgery on the second symptomatic hip in bilateral femoroacetabular impingement syndrome remains uncertain. Simultaneous bilateral surgery is demanding for patients, with many surgeons preferring staged procedures. Unfortunately for the evidence‐based hip arthroscopist, prior studies have identified conflicting thresholds for the interval between procedures beyond which patient outcomes may decline. The literature supporting this decision is often underpowered to detect differences in failure rates and seldom accounts for the progression of osteoarthritis. Without definitive evidence, the interval between hip procedures should remain a shared decision. Shorter staging intervals may suit patients with bilateral symptoms and sport‐ or work‐related time constraints, although they risk overtreating a contralateral hip that may improve without surgery. Longer staging allows the first hip to recover, but risks prolonged pain and progression of intra‐articular pathology. Adequately powered prospective studies that stratify patients by bilateral symptom status at presentation are needed before we consider adjusting our clinical practice.